Prime-Pull Immunization with a Bivalent M-Protein and Spy-CEP Peptide Vaccine Adjuvanted with CAF®01 Liposomes Induces Both Mucosal and Peripheral Protection from covR/S Mutant Streptococcus pyogenes-Reference-Cited by-同舟云学术

Prime-Pull Immunization with a Bivalent M-Protein and Spy-CEP Peptide Vaccine Adjuvanted with CAF®01 Liposomes Induces Both Mucosal and Peripheral Protection from covR/S Mutant Streptococcus pyogenes

Published:2021-02-23 Issue:1 Volume:12 Page:
ISSN:2150-7511
Container-title:mBio
language:en
Short-container-title:mBio

Author:

Ozberk Victoria¹,Reynolds Simone¹,Huo Yongbao¹,Calcutt Ainslie¹,Eskandari Sharareh¹,Dooley Jessica¹,Mills Jamie-Lee¹,Rasmussen Ida S.²,Dietrich Jes²,Pandey Manisha¹,Good Michael F.¹

Affiliation:

1. Institute for Glycomics, Griffith University, Gold Coast, Australia

2. Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark

Abstract

A vaccine to control S. pyogenes infection is desperately warranted. S. pyogenes colonizes the upper respiratory tract (URT) and skin, from where it can progress to invasive and immune-mediated diseases.

Funder

Department of Health, Australian Government | National Health and Medical Research Council

Publisher

American Society for Microbiology

Subject

Virology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/mBio.03537-20

Reference42 articles.

1. The global burden of group A streptococcal diseases

2. Global, Regional, and National Burden of Rheumatic Heart Disease, 1990–2015

3. The WHF Roadmap for Reducing CV Morbidity and Mortality Through Prevention and Control of RHD